These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36279508)

  • 1. Development of an In Vitro System To Emulate an In Vivo Subcutaneous Environment: Small Molecule Drug Assessment.
    Lou H; Hageman MJ
    Mol Pharm; 2022 Nov; 19(11):4017-4025. PubMed ID: 36279508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Drug Release Model for Suspensions in ESCAR (Emulator of SubCutaneous Absorption and Release).
    Lou H; Hageman MJ
    AAPS J; 2023 Mar; 25(3):29. PubMed ID: 36949301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel extended IVIVC combined with DoE to predict pharmacokinetics from formulation compositions.
    Lim JY; Kim TH; Song CH; Kim DH; Shin BS; Shin S
    J Control Release; 2022 Mar; 343():443-456. PubMed ID: 35124130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of Level a In Vitro-In Vivo Correlation (IVIVC) via Extended DoE-IVIVC Model: A Donepezil Case Study.
    Lee DY; Shin S; Kim TH; Shin BS
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel in vitro method to model the fate of subcutaneously administered biopharmaceuticals and associated formulation components.
    Kinnunen HM; Sharma V; Contreras-Rojas LR; Yu Y; Alleman C; Sreedhara A; Fischer S; Khawli L; Yohe ST; Bumbaca D; Patapoff TW; Daugherty AL; Mrsny RJ
    J Control Release; 2015 Sep; 214():94-102. PubMed ID: 26210441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Perspective on Model-Informed IVIVC for Development of Subcutaneous Injectables.
    Corpstein CD; Li T
    Pharm Res; 2023 Jul; 40(7):1633-1639. PubMed ID: 37523013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro-In Vivo Correlation (IVIVC) Population Modeling for the In Silico Bioequivalence of a Long-Acting Release Formulation of Progesterone.
    Tosca EM; Rocchetti M; Pérez E; Nieto C; Bettica P; Moscoso Del Prado J; Magni P; De Nicolao G
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33673306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.
    Leal LB; Cordery SF; Delgado-Charro MB; Bunge AL; Guy RH
    Pharm Res; 2017 Apr; 34(4):730-737. PubMed ID: 28097506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of in vitro-in vivo correlation (IVIVC) for estradiol transdermal drug delivery systems.
    Yang Y; Manda P; Pavurala N; Khan MA; Krishnaiah YS
    J Control Release; 2015 Jul; 210():58-66. PubMed ID: 25979329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of Drug Delivery in Rats via Subcutaneous Injection: Case Study of Pharmacokinetic Modeling of Suspension Formulations.
    Chiang PC; Nagapudi K; Fan PW; Liu J
    J Pharm Sci; 2019 Jan; 108(1):109-119. PubMed ID: 29909029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulating particle movement inside subcutaneous injection site simulator (SCISSOR) using Monte-Carlo method.
    Lou H; Berkland C; Hageman MJ
    Int J Pharm; 2021 Aug; 605():120824. PubMed ID: 34171429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Need for Bioequivalence Standards that Reflect the Clinical Importance of the Complex Pharmacokinetics of Paliperidone Palmitate Long-Acting Injectable Suspension.
    Procyshyn RM; Lamoure JW; Katzman MA; Skinner PL; Sherman SE
    J Pharm Pharm Sci; 2019; 22(1):548-566. PubMed ID: 31730504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of Bioequivalent Extended-Release Formulations for Metformin by Principal Component Analysis and Convolution-Based IVIVC Approach.
    Zhang Y; Liu H; Tang MJ; Ho NJ; Shek TL; Yang Z; Zuo Z
    AAPS J; 2021 Mar; 23(2):38. PubMed ID: 33665728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Convenient In Vitro Gel Diffusion Model for Predicting the In Vivo Performance of Subcutaneous Parenteral Formulations of Large and Small Molecules.
    Leung DH; Kapoor Y; Alleyne C; Walsh E; Leithead A; Habulihaz B; Salituro GM; Bak A; Rhodes T
    AAPS PharmSciTech; 2017 Aug; 18(6):2203-2213. PubMed ID: 28070846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melt extrusion deposition (MED™) 3D printing technology - A paradigm shift in design and development of modified release drug products.
    Zheng Y; Deng F; Wang B; Wu Y; Luo Q; Zuo X; Liu X; Cao L; Li M; Lu H; Cheng S; Li X
    Int J Pharm; 2021 Jun; 602():120639. PubMed ID: 33901601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental design, development and evaluation of extended release subcutaneous thermo-responsive
    Sharma D; Atassi F; Cook S; Marden S; Wang J; Xue A; Wagner DJ; Zhang G; Yang W
    Pharm Dev Technol; 2021 Dec; 26(10):1079-1089. PubMed ID: 34558389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulate SubQ: The Methods and the Media.
    Li D; Chow PY; Lin TP; Cheow C; Li Z; Wacker MG
    J Pharm Sci; 2023 Jun; 112(6):1492-1508. PubMed ID: 34728176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro-in vivo correlation of inhalable budesonide-loaded large porous particles for sustained treatment regimen of asthma.
    Li J; Zheng H; Qin L; Xu EY; Yang L; Zhang L; Zhang X; Fan L; Beck-Broichsitter M; Muenster U; Chen L; Zhang Y; Mao S
    Acta Biomater; 2019 Sep; 96():505-516. PubMed ID: 31265921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Accelerated Release Method of Risperidone Loaded PLGA Microspheres with Good IVIVC.
    Hu X; Zhang J; Tang X; Li M; Ma S; Liu C; Gao Y; Zhang Y; Liu Y; Yu F; Yang Y; Guo J; Li Z; Mei X
    Curr Drug Deliv; 2018; 15(1):87-96. PubMed ID: 28521697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.